Skip to main content
Caplight Logo









Kindling Bio

Kindling Bio

Private
LondonHealthcare & Life Scienceshttps://www.kindlingbio.com/

Last Round

Grant

Dec 3, 2025

Total Funding Raised

$428,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Kindling Bio is a biotechnology company that develops pediatric-led, next-generation cancer gene therapies designed to reprogram tumor biology and harness children's immune responses to fight a wide range of tumors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

gene therapypediatric oncologycancer immunotherapysolid tumor therapyviral vectortumor reprogrammingbiotech startupdrug discoveryprecision medicinenext-gen therapeuticspreclinical researchonco-immunologycell engineering

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Kindling Bio Comparables

Compare Kindling Bio with similar companies based on industry and business-model similarity.

Kindling Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BrainChild Bio, Inc.
79%
Spes Immunotherapeutics
71%
Immugenia Inc.
71%

Kindling Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 3, 2025
SeedOct 1, 2025

Kindling Bio Investors

Notable investors and investment history

Kindling Bio investors
InvestorRounds
Deep Science VenturesSeed
Innovate UKSeed
Paris-Saclay Cancer ClusterGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 3, 2025

    $108K raised from Paris-Saclay Cancer Cluster

  • Oct 1, 2025

    $320K round with Deep Science Ventures and Innovate UK

Kindling Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Kindling Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Kindling Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range2
Year Founded2025
Last FundingDec 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?